Free Trial

Alexion Pharmaceuticals (ALXN) ESG Score & Sustainability Data

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)
Free ALXN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Sustainability
Stock Analysis

Key ESG Takeaways for Alexion Pharmaceuticals

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Alexion Pharmaceuticals. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Alexion Pharmaceuticals seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is driven by its Eculizumab, Preclinical research services, and Clinical research services products.
  • Alexion Pharmaceuticals uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category is driven by its Eculizumab, Clinical research services, and Preclinical research services products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services business, Alexion Pharmaceuticals would improve its net impact ratio by 4 percentage points.

ALXN Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+49.1%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+52.0%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+32.8%
Society First
Value set that emphasizes society impacts over other impacts.
-32.2%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+59.1%
Health First
Value set that emphasizes health impacts over other impacts.
+74.3%

Alexion Pharmaceuticals ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+0.93
+0.93
+1.76
+1.76
+0.03
+0.03
-0.02
-0.02
+0.00
-0.79
-0.77
+0.02
0.00
+0.00
+0.57
+0.57
-0.00
+0.00
+0.00
-1.14
-1.14
-0.93
+4.32
+5.26
-0.03
+0.40
+0.42
+0.00
+0.00
-0.00
+0.03
+0.03
-0.01
+0.43
+0.43
-0.91
-0.89
+0.02
-0.50
-0.50
+0.01
-0.03
-0.03
+0.00
-0.10
-0.10
+0.00
-0.36
-0.36
+0.00

Upright Model Version 1.0.0
ESG Data Last Updated: April 21, 2023

Ad Behind the Markets
The only defense company you should be looking at
This is the ONLY defense company you should be watching right now.
Get all the info here >>>

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Alexion Pharmaceuticals ESG Score - Frequently Asked Questions

How is Alexion Pharmaceuticals doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Alexion Pharmaceuticals has a net impact ratio of 49.1%, indicating an overall positive sustainability impact. Alexion Pharmaceuticals seems to create the most significant positive value in the categories of Physical diseases, Taxes, and Jobs. Alexion Pharmaceuticals uses resources or causes negative impacts mostly in the categories of Scarce human capital, Physical diseases, and GHG emissions. Learn more on the sustainability of Alexion Pharmaceuticals.


More ESG Stocks and Research Tools

Related Companies:
Stock Lists:
Sustainability Tools:
This page (NASDAQ:ALXN) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
SHOCKING Crypto Leak…
Crypto 101 Media
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
The Next Nvidia?
InvestorPlace
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Great Crypto Bull
Weiss Ratings